The multicentre exchange and multidisciplinary data analysis improves the clinical classification of the genetic variants that predispose to cancer
This may be gathered from the results [...]
Under a Cancer Cell Spotlight: unleashing the promise of KRAS targeting therapy
Published today in Cancer Cell* as a [...]
RAPIDO study shows promise for the optimal treatment of high-risk locally advanced rectal cancer
Results from the RAPIDO phase III multicenter, [...]
VHIO’s Ana Oaknin elected as co-Chair of the Gynecologic Cancer InterGroup’s Cervix Cancer Committee
News just in, Principal Investigator of our [...]
Precision medicine against metastatic prostate cancer: proposed actions to reverse current challenges
Barcelona, November 26, 2020.- Despite recent progress in [...]
Recognized by their peers, applauded by the world: VHIO’s Josep Tabernero and Enriqueta Felip among Clarivate’s 6,167 Global Highly Cited Researchers 2020
Barcelona, November 18th, 2020.- Published today, Clarivate’s Web [...]
Strengthening cancer control & prevention: ESMO and IACR co-launch the World Cancer Report’s e-learning platform
Launching this coming Thursday 19 November, the [...]
Countdown to World Cancer Day 04 February: the 21 Days to Impact Challenge
February 04, 2021 will not only celebrate [...]
Movember movement against prostate cancer: much more than moustaches
Movember, celebrated globally throughout the month of [...]
VHIO in 2019: tick tock toward 2025
The number 25 is the focus of [...]